These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27130)

  • 21. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC; Frohlich ED; de Carvalho JG; Dunn FG; Chrysant SG; Danisa K; Wambach G
    Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866
    [No Abstract]   [Full Text] [Related]  

  • 22. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP; Ledingham JG
    Clin Sci Mol Med; 1978 Mar; 54(3):305-12. PubMed ID: 630806
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK; Williams GH; Adams DF; Moore T; Brown C; Borucki LJ; Leung F; Bavli S; Solomon HS; Passan D; Dluhy R
    Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
    Kreft C; Menard J; Corvol P
    Kidney Int; 1979 Feb; 15(2):176-83. PubMed ID: 513483
    [No Abstract]   [Full Text] [Related]  

  • 25. Renin release, an artifact of anesthesia and its implications in rats.
    Pettinger WA; Tanaka K; Keeton K; Campbell WB; Brooks SN
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):625-30. PubMed ID: 1129282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
    Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of inhalation and intravenous anesthetic agents on pressor response to NG-nitro-L-arginine.
    Wang YX; Zhou T; Chua TC; Pang CC
    Eur J Pharmacol; 1991 Jun; 198(2-3):183-8. PubMed ID: 1864305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent depression of cardiac function and metabolism by inhalation anesthetics in chronically instrumented dogs.
    Merin RG; Kumazawa T; Luka NL
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():473-80. PubMed ID: 22904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma renin response to acute blockade of angiotensin II in the anaesthetized rat.
    Oates HF; Stokes GS; Glover RG
    Clin Exp Pharmacol Physiol; 1974; 1(2):155-60. PubMed ID: 4156503
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of blood pressure by beta adrenoceptor mediated renin release during different forms of anesthesia in rats.
    Leenen FH; Provoost AP
    Can J Physiol Pharmacol; 1981 Apr; 59(4):364-70. PubMed ID: 6263433
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and experimental studies on the angiotensin inhibitor 1-sar-8-ile-angiotensin II (P 165)].
    Werner U; Waelsch I; Bock KD
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1310-3. PubMed ID: 1029986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.